Brief: VibroSense Applies For A Patent
04/03/2021 07:38
March 4 (Reuters) - VibroSense Dynamics AB VSDYNb.TE :
* APPLIES FOR PATENT ON BIOMARKER TO PREDICT THE RISK OF
NERVE
DAMAGE CAUSED BY CHEMOTHERAPY
* PATENT APPLICATION IS BASED ON A STUDY CONDUCTED DURING
2018-2020, ON PATIENTS WITH COLORECTAL CANCER TREATED WITH
OXALIPLATIN-BASED DRUGS
Source text for Eikon: ID:nWkr3ttCYn
Further company coverage: VSDYNb.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Vibrosense Dynamics AB
See all newsBrief: VibroSense Dynamics AB Says Regulatory Approval Of Vibrosense Meter In China Is Delayed 4 Months
Brief: VibroSense Applies For A Patent
Brief: Vibrosense Dynamics Q2 Pretax Loss Unchanged At SEK 2.1 Mln
Brief: VibroSense Dynamics Deal With Inission As Production Partner
Brief: VibroSense Dynamics Signs Agreement With Inission As Production Partner